• Patient Site
  • V-Go Customer Care
vgo green
New Look, Same V-Go®
  • New Look, Same V-Go
  • Call 1-866-881-1209
  • About V-Go
    • What is V-Go®?
    • Who is it For?
    • How it Works
    • Why V-Go®?
  • Clinical Data
    • Optimize Delivery
    • Efficacy
    • Insulin Reduction
    • Patient Adherence
  • Prescribing & Dosing
    • Overview
  • Patient Support
    • Starting Patients
    • Comprehensive Support for You and Your Patients
    • Common Patient Questions
    • Same V-Go, New Look
  • Coverage & Savings
    • Overview
  • Pharmacists
    • Overview
    • Reimbursement Card
    • New Look, Same V-Go

Simplified Insulin Delivery
Worn Like a Patch

V-Go is an easy-to-use, wearable insulin device that:

  • Provides glucose control without multiple daily injections
    (MDI)1
  • Releases a steady rate of rapid-acting† insulin for basal control2
  • Delivers prandial insulin at the click of a button2

V-Go indicated for use in adult patients requiring insulin.
†A U-100 fast- acting insulin should be used with V-Go. Humalog® (insulin lispro [rDNA origin] injection) and NovoLog® (insulin aspart [rDNA origin] injection) have been tested and found to be safe for use in V-Go.

Humalog® is a registered trademark of Eli Lilly and Company.

NovoLog® is a registered trademark of Novo Nordisk A/S.

Woman modeling the V-Go® device

John Sink

Control and compliance for your patients

  • V-Go delivers a continuous preset basal rate of insulin over 24 hours while providing discreet on-demand bolus insulin dosing at mealtimes with simple clicks2
  • Easy-to-use wearable insulin device helps support adherence and improve glycemic control1-6

PLAY VIDEO

An Expert’s Perspective: The Value of V-Go for Patients on MDI

Hear a Nurse Practitioner talk about how V-Go can help overcome the burdens of adherence to multiple daily injections, resulting in an increase in morale for her patients and better compliance.

PLAY VIDEO

Value of V-Go

References: 1. Lajara R, Fetchick DA, Morris DA, Nikkel C. Use of V-Go® insulin delivery device with sub-optimally controlled diabetes mellitus: a retrospective analysis from a large specialized diabetes system. Diabetes Ther. 2015;6(4):531-545. 2. Instructions for Patient Use. P/N 2614-00 Rev. A 05/2019. 3. Lajara R, Davidson JA, Nikkel C, Morris TL. Clinical and cost effectiveness of insulin delivery with V-Go disposable insulin delivery device versus multiple daily injections in patients with type 2 diabetes inadequately controlled on basal insulin. Endocrine Practice 2016 June;22(6):726-735. 4. Grunberger G, Rosenfeld CR, Bode BW, Abbott SD, Nikkel C, Shi L, Strange P. Effectiveness of V-Go for Patients with Type 2 Diabetes in a Real-World Setting: A Prospective Observational Study. Drugs Real World Outcomes. 2020 Mar;7(1):31-40. 5. Sutton D, Higdon C, Nikkel C, Hilsinger K. Clinical benefits over time associated with use of V-Go Wearable Insulin Delivery Device in adult patients with diabetes: a retrospective analysis. Advances in Therapy 2018 May; 35(5): 631-43. 6. Rosenfeld CR, Bohannon NJ, Bode B, et al. Endocrine Practice. 2012;18(5):660-667.

Important Risk Information

If regular adjustments or modifications to the basal rate of insulin are required in a 24-hour period, or if the amount of insulin used at meals requires adjustments of less than 2-Unit increments, use of the V-Go Wearable Insulin Delivery Device may result in hypoglycemia. The following conditions may occur during insulin therapy with V-Go: hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose). Other adverse reactions associated with V-Go use include skin irritation from the adhesive pad or infections at the infusion site. V-Go should be removed before any magnetic resonance imaging (MRI) testing.

  • Product Specs
  • Important Safety Information
  • Contact Us
  • Zealand Pharma
  • Terms of Use & Privacy
  • Cookies
  • Site Map
  • Twitter
  • YouTube
Zealand Pharma Logo Neg (Mar2020) 316x116
White V-Go® logo
© 2020 Zealand Pharma A/S
This website uses cookies to improve your browsing experience. Read MoreAccept
Cookies Policy
Necessary Always Enabled